Studies have shown that mutations in the MAPK/ERK pathway (KRAS), p53 pathway (TP53), Wnt/β catenin pathway (APC), and the PI3K/Atk pathway (PIK3CA) in clinical CRC samples from patients are the most influential drivers of liver metastasis. The gene discussed is PIK3CA; the disease is colorectal carcinoma.